Skip to main content Accessibility help
×
Hostname: page-component-78c5997874-s2hrs Total loading time: 0 Render date: 2024-11-09T20:22:32.221Z Has data issue: false hasContentIssue false

21 - Malignancy and pregnancy

from Section 5 - Other disorders

Published online by Cambridge University Press:  19 October 2009

Holly A. Muir
Affiliation:
Vice Chair, Clinical Operations Department of Anesthesiology, Duke University, Medical Center, Durham, North Carolina, USA; Chief, Division of Women's Anesthesia
Michael Smith
Affiliation:
Chief Resident in Anesthesiology, Department of Anaesthesiology, University of Kansas, School of Medicine – Wichita, Wichita, KS, USA
David R. Gambling
Affiliation:
Clinical Associate Professor, Department Anesthesiology, University of California, San Diego, CA USA; Staff Anesthesiologist, Sharp Mary Birch Hospital for Women
David R. Gambling
Affiliation:
University of California, San Diego
M. Joanne Douglas
Affiliation:
University of British Columbia, Vancouver
Robert S. F. McKay
Affiliation:
University of Kansas
Get access

Summary

Introduction

Malignancy complicates between 0.02% and 0.10% of all pregnancies and in one study cancer diagnosis was associated with 1 in 1000 deliveries. Pregnancy does not affect the frequency of cancers seen in women of childbearing age. Melanoma may be the most frequent malignancy seen during pregnancy (1:350), followed by cervical cancer (1:2250), Hodgkin lymphoma (1:3000), breast cancer (1:7500), ovarian cancer (1:18,000), and leukemia (1:75,000). However, the National Cancer Institute maintains that breast cancer is the most common cancer seen in pregnant and postpartum women at 1:3000 pregnancies (www.cancer.gov/cancertopics/pdq/treatment/breast-cancer-and-pregnancy).

In general, the prognosis for pregnant women with malignant lesions is the same, stage for stage, as for nonpregnant women. However, for many reasons, diagnosis of cancer during pregnancy occurs at more advanced stages of the disease.

Typically, during pregnancy, what benefits the mother also benefits the fetus. However, that is not true in the case of the pregnant woman with cancer as treating the cancer often means compromising the pregnancy. Depending on the type of cancer and gestational age at diagnosis, treatment can sometimes be delayed until the fetus is either viable or mature. In some cases, protection of maternal and fetal health are congruent, but when care of the mother imposes iatrogenic risk to the fetus, the mother may decide to delay or alter her treatment for the good of the fetus, potentially to her own detriment.

Fetal monitoring

Fetal and uterine monitoring during cancer surgery is controversial.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Smith, L. H., Danielsen, B., Allen, M. E. & Cress, R.Cancer associated with obstetric delivery: results of linkage with the California cancer registry. Am. J. Obstet. Gynecol. 2003; 189: 1128–35.Google Scholar
Cunningham, F. G., Hauth, J. C., Leveno, K. J.et al. (eds). Chapter 57: Neoplastic diseases. In Williams Obstetrics, 22nd ed. New York: McGraw Hill, 2005.
Rosen, M. A.Management of anesthesia for the pregnant surgical patient. Clinical concepts and commentary. Anesthesiology 1999; 91: 1159.Google Scholar
Berry, D. L., Theriault, R. L., Holmes, F. A.et al. Management of breast cancer during pregnancy using a standardized protocol. J. Clin. Oncol. 1999; 17: 855–61.Google Scholar
Weisz, B., Schiff, E. & Lishner, M.Cancer in pregnancy: maternal and fetal implications. Hum. Reprod. Update 2001; 7: 384–93.Google Scholar
Eedarapalli, P. & Jain, S.Breast cancer in pregnancy. J. Obstet. Gynaecol. 2006; 26: 1–4.Google Scholar
Nettleton, J., Long, J., Kuban, D.et al. Breast cancer during pregnancy: quantifying the risk of treatment delay. Obstet. Gynecol. 1996; 87: 414–18.Google Scholar
Gallenberg, M. M. & Loprinzi, C. L.Breast cancer and pregnancy. Semin. Oncol. 1989; 16: 369–76.Google Scholar
Carlson, R. W., Brown, E., Burstein, H. J.et al. for the National Comprehensive Cancer Network. NCCN Task Force Report: Adjuvant Therapy for Breast Cancer. J. Natl. Compr. Canc. Netw. 2006; 4: S1–26.Google Scholar
Marchant, D. J.Breast cancer in pregnancy. Clin. Obstet.Gynecol. 1994; 37: 993–7.Google Scholar
Hebl, J. R., Horlocker, T. T. & Pritchard, D. J.Diffuse brachial plexopathy after interscalene blockade in a patient receiving cisplatin chemotherapy: the pharmacologic double crush syndrome. Anesth. Analg. 2001; 92: 249–51.Google Scholar
Burrows, F. A., Hickey, P. R. & Colan, S.Perioperative complications in patients with anthracycline chemotherapeutic agents. Can. Anaesth. Soc. J. 1985; 32: 149–57.Google Scholar
Buvanendran, A., Mohajer, P., Pombar, X. & Tuman, K. J.Perioperative management with epidural anesthesia for a parturient with superior vena caval obstruction. Anesth. Analg. 2004; 98: 1160–3.Google Scholar
Stamatiou, G., Athanasiou, E., Simeoforidou, M., Bakos, P. & Michaloudis, D.Thoracic paravertebral block for breast surgery. Anaesthesia 2004; 59: 723–4.Google Scholar
Muller, C. Y. & Smith, H. O.Cervical neoplasia complicating pregnancy. Obstet. Gynecol. Clin. North Am. 2005; 32: 533–46.Google Scholar
Sood, A. K. & Sorosky, J. I.Invasive cervical cancer complicating pregnancy. How to manage the dilemma. Obstet. Gynecol. Clin. North Am. 1998; 25: 343–52.Google Scholar
Kyrgious, M., Koliopoulos, G., Martin-Hirsch, P.et al. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet 2006; 367: 489–98.Google Scholar
Stan, C., Megevand, E., Irion, O.et al. Cervical cancer in pregnant women: laparoscopic evaluation before delaying treatment. Eur. J. Gynaecol. Oncol. 2005; 26: 649–50.Google Scholar
Duggan, B., Muderspach, L. I., Roman, L. D.et al. Cervical cancer in pregnancy: reporting on planned delay in therapy. Obstet. Gynecol. 1993; 82: 598–602.Google Scholar
Ungar, L., Smith, J. R., Palfalvi, L. & Del Priore, G.Abdominal radical trachelectomy during pregnancy to preserve pregnancy and fertility. Obstet. Gynecol. 2006; 108: 811–14.Google Scholar
Kay, T. A., Renninson, J. N., Shepherd, J. H. & Taylor, M. J.Successful pregnancy following radical trachelectomy and in vitro fertilization with ovum donation. Br. J. Obstet. Gynaecol. 2006; 113: 965–6.Google Scholar
Vange, N., Weverling, G. J., Ketting, B. W.et al. The prognosis of cervical cancer associated with pregnancy: a matched cohort study. Obstet. Gynecol. 1995; 85: 1022–6.Google Scholar
O'Rourke, N. & Kodali, B. S.Laparoscopic surgery during pregnancy. Curr. Opin. Anaesthesiol. 2006; 19: 254–9.Google Scholar
Leiserowitz, G. S., Xing, G., Cress, R.et al. Adnexal masses in pregnancy: how often are they malignant?Gynecol. Oncol. 2006; 101: 315–21.Google Scholar
Bandera, C. A.Advances in the understanding of risk factors for ovarian cancer. J. Reprod. Med. 2005; 50: 399–406.Google Scholar
Schmeler, K. M., Mayo-Smith, W. W., Peipert, J. F.et al. Adnexal masses in pregnancy: surgery compared with observation. Obstet. Gynecol. 2005; 105: 1098–103.Google Scholar
Giuntoli, R. L. 2nd, Vang, R. S. & Bristow, R. E.Evaluation and management of adnexal masses during pregnancy. Clin. Obstet. Gynecol. 2006; 49: 492–505.Google Scholar
Leiserowitz, G. S.Managing ovarian masses during pregnancy. Obstet. Gynecol. Surv. 2006; 61: 463–70.Google Scholar
Nishio, S., Ushijima, K., Fukui, A.et al. Fertility-preserving treatment for patients with malignant germ cell tumors of the ovary. J. Obstet. Gynaecol. Res. 2006; 32: 416–21.Google Scholar
Mantovani, G., Mais, V., Parodo, G.et al. Use of chemotherapy for ovarian cancer during human pregnancy: case report and literature review. Eur. J. Obstet. Gynecol. Reprod. Biol. 2007; 131: 238–9.Google Scholar
Han, J. Y., Nava-Ocampo, A. A., Kim, T. J., Shim, J. U. & Park, C. T.Pregnancy outcome after prenatal exposure to bleomycin, etoposide and cisplatin for malignant ovarian germ cell tumors: report of 2 cases. Reprod. Toxicol. 2005; 19: 557–61.Google Scholar
Patterson, D. M. & Rustin, G. J.Controversies in the management of germ cell tumors of the ovary. Curr. Opin. Oncol. 2006; 18: 500–6.Google Scholar
Mathevet, P., Nessah, K., Dargent, D. & Mellier, G.Laparoscopic management of adnexal masses in pregnancy: a case series. Eur. J. Obstet. Gynecol. Reprod. Biol. 2003; 108: 217–22.Google Scholar
Tanaka, H., Futamura, N., Takubo, S. & Toyoda, N.Gasless laparoscopy under epidural anesthesia for adnexal cysts during pregnancy. J. Reprod. Med. 1999; 44: 929–32.Google Scholar
Sivanesaratnam, V.Management of the pregnant mother with malignant conditions. Curr. Opin. Obstet. Gynecol. 2001; 13: 121–5.Google Scholar
Park, J. C., Cho, C. H. & Rhee, J. H.A successful live birth through in vitro fertilization program after conservative treatment of FIGO grade 1 endometrial cancer. J. Korean Med. Sci. 2006; 21: 567–71.Google Scholar
Sparac, V., Ujevic, B., Ujevic, M.et al. Successful pregnancy after hysteroscopic removal of grade 1 endometrial carcinoma in a young woman with Lynch syndrome. Int. J. Gynecol. Cancer 2006; 16: 442–5.Google Scholar
Ferrandina, G., Zannoni, G. F., Gallotta, V.et al. Progression of conservatively treated endometrial carcinoma after full term pregnancy: a case report. Gynecol. Oncol. 2005; 99: 215–17.Google Scholar
Ogunleye, D., Lewin, S. N., Huettner, P. & Herzog, T. J.Recurrent vulvar carcinoma in pregnancy. Gynecol. Oncol. 2004; 95: 400–1.Google Scholar
Gitsch, G., Eijkeren, M. & Hacker, N. F.Surgical therapy of vulvar cancer in pregnancy. Gynecol. Oncol. 1995; 56: 312–15.Google Scholar
Bradley, P. J. & Raghavan, U.Cancers presenting in the head and neck during pregnancy. Curr. Opin. Otolaryngol. Head Neck Surg. 2004; 12: 76–81.Google Scholar
Lao, T.Thyroid disorders in pregnancy. Clin. Opin. Obstet. Gynecol. 2005; 17: 123–7.Google Scholar
Layton, S. A., Rintoul, M. & Avery, B. S.Oral carcinoma in pregnancy. Br. J. Oral Maxillofac. Surg. 1992; 30: 161–4.Google Scholar
Ferlito, A., Devaney, S. L., Carbone, A.et al. Pregnancy and malignant neoplasms of the head and neck. Ann. Otol. Rhinol. Laryngol. 1998, 107: 991–8.Google Scholar
Yasmeen, S., Cress, R., Romano, P. S.et al. Thyroid cancer in pregnancy. Int. J. Gynaecol. Obstet. 2005; 91: 15–20.Google Scholar
Reddy, S. P., Mohideen, N., Marra, S. & Marks, J. E.Effect of tumor bulk on local control and survival of patients with T1 glottic cancer. Radiother. Oncol. 1998; 47: 161–6.Google Scholar
Tewari, K. S., Cappuccini, F., Asrat, T.et al. Obstetric emergencies precipitated by malignant brain tumors. Am. J. Obstet. Gynecol. 2000; 182: 1215–21.Google Scholar
Stevenson, C. B. & Thompson, R. C.The clinical management of intracranial neoplasms in pregnancy. Clin. Obstet. Gynecol. 2005; 48: 24–37.Google Scholar
Giannini, A. & Bricchi, M.Posterior fossa surgery in the sitting position in a pregnant patient with cerebellopontine angle meningioma. Br. J. Anaesth. 1999; 82: 941–4.Google Scholar
Balki, M. & Manninen, P. H.Craniotomy for suprasellar meningioma in a 28-week pregnant woman without fetal heart rate monitoring. Can. J. Anaesth. 2004; 51: 573–6.Google Scholar
Smith, I. F. & Skelton, V.An unusual intracranial tumour presenting in pregnancy. Int. J. Obstet. Anesth. 2007; 16: 82–5.Google Scholar
Smith, H. O., Kohorn, E. & Cole, L. A.Choriocarcinoma and gestational trophoblastic disease. Obstet. Gynecol. Clin. North Am. 2005; 32: 661–84.Google Scholar
Smith, H. O., Hilgers, R. D., Bedrick, E. J.et al. Ethnic differences in risk for gestational trophoblastic disease in New Mexico: a 25-year population-based study. Am. J. Obstet. Gynecol. 2003; 188: 357–66.Google Scholar
Bristow, R., Shumway, J., Khouzami, A. & Witter, F.Complete hydatidiform mole and surviving coexistent twin. Obstet. Gynecol. Surv. 1996; 51: 705–9.Google Scholar
Lewis, J. L. Jr. Diagnosis and management of gestational trophoblastic disease. Cancer 1993; 71: 1639–47.Google Scholar
Kendall, A., Gillmore, R. & Newlands, E.Chemotherapy for trophoblastic disease: current standards. Curr. Opinion Obstet. Gynecol. 2002; 14: 33–8.Google Scholar
Kohorn, E. I.The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: description and critical assessment. Int. J. Gynecol. Cancer 2001; 11: 73–7.Google Scholar
Benedet, J. L., Bender, H., Jones, H. 3rd. Ngan, H. Y. S. & Pecorelli, S.Staging classifications and clinical practice guidelines of gynaecologic cancers. FIGO Committee on Gynecologic Oncology. Int. J. Gynecol. Obstet. 2000; 70: 207–312.Google Scholar
Xue, Y., Zhang, J., Wu, T. X. & An, R. F.Combination chemotherapy for high-risk gestational trophoblastic tumour. Cochrane Database Syst. Rev. 2006; 19: CD005196.Google Scholar
Seckl, M. J. & Newlands, E. S., Treatment of gestational trophoblastic disease. Gen. Diagn. Pathol. 1997; 143: 159–71.Google Scholar
Solak, M. & Akturk, G.Spinal anesthesia in a patient with hyperthyroidism due to hydatidiform mole. Anesth. Analg. 1993; 77: 851–2.Google Scholar
Soper, J.Gestational trophoblastic disease. Obstet. Gynecol. 2006; 108: 176–87.Google Scholar
Kvolik, S., Glavas-Obrovac, L., Sakic, K.et al. Anaesthetic implications of anticancer chemotherapy. Eur. J. Anaesthesiol. 2003; 20: 859–71.Google Scholar
Burlacu, C. L., Fitzpatrick, C. & Carey, M.Anaesthesia for caesarean section in a woman with lung cancer: case report and review. Int. J. Obstet. Anesth. 2007; 16: 50–62.Google Scholar
Jackisch, C., Louwen, F., Schwenkhagen, A.et al. Lung cancer during pregnancy involving the products of conception and a review of the literature. Arch. Gynecol. Obstet. 2003; 268: 69–77.Google Scholar
Bahador, A., Lowe, M. P., Cheng, J. & Roman L. D. Gynecologic cancer in pregnancy. In Gershenson, D. M., McGuire, W. P., Gore, M., Quinn, M. A. & Thomas, G. (eds.), Gynecologic Cancer. Livingstone, Philadelphia: Elsevier Churchill, 2004.

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Malignancy and pregnancy
    • By Holly A. Muir, Vice Chair, Clinical Operations Department of Anesthesiology, Duke University, Medical Center, Durham, North Carolina, USA; Chief, Division of Women's Anesthesia, Michael Smith, Chief Resident in Anesthesiology, Department of Anaesthesiology, University of Kansas, School of Medicine – Wichita, Wichita, KS, USA, David R. Gambling, Clinical Associate Professor, Department Anesthesiology, University of California, San Diego, CA USA; Staff Anesthesiologist, Sharp Mary Birch Hospital for Women
  • Edited by David R. Gambling, University of California, San Diego, M. Joanne Douglas, University of British Columbia, Vancouver, Robert S. F. McKay, University of Kansas
  • Book: Obstetric Anesthesia and Uncommon Disorders
  • Online publication: 19 October 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511544552.022
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Malignancy and pregnancy
    • By Holly A. Muir, Vice Chair, Clinical Operations Department of Anesthesiology, Duke University, Medical Center, Durham, North Carolina, USA; Chief, Division of Women's Anesthesia, Michael Smith, Chief Resident in Anesthesiology, Department of Anaesthesiology, University of Kansas, School of Medicine – Wichita, Wichita, KS, USA, David R. Gambling, Clinical Associate Professor, Department Anesthesiology, University of California, San Diego, CA USA; Staff Anesthesiologist, Sharp Mary Birch Hospital for Women
  • Edited by David R. Gambling, University of California, San Diego, M. Joanne Douglas, University of British Columbia, Vancouver, Robert S. F. McKay, University of Kansas
  • Book: Obstetric Anesthesia and Uncommon Disorders
  • Online publication: 19 October 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511544552.022
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Malignancy and pregnancy
    • By Holly A. Muir, Vice Chair, Clinical Operations Department of Anesthesiology, Duke University, Medical Center, Durham, North Carolina, USA; Chief, Division of Women's Anesthesia, Michael Smith, Chief Resident in Anesthesiology, Department of Anaesthesiology, University of Kansas, School of Medicine – Wichita, Wichita, KS, USA, David R. Gambling, Clinical Associate Professor, Department Anesthesiology, University of California, San Diego, CA USA; Staff Anesthesiologist, Sharp Mary Birch Hospital for Women
  • Edited by David R. Gambling, University of California, San Diego, M. Joanne Douglas, University of British Columbia, Vancouver, Robert S. F. McKay, University of Kansas
  • Book: Obstetric Anesthesia and Uncommon Disorders
  • Online publication: 19 October 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511544552.022
Available formats
×